Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
The Cure Parkinson's Trust

Help us fund research to slow, stop and reverse Parkinson’s

Donate
  • Twitter
Menu
  • Home
  • Our research
    • Our mission
    • Clinical trials
    • Projects and progress
    • Research Focused Webinars
    • 3P Seminars: The Postdoc Program
    • Improving the clinical trial process
    • Apply for funding
    • Research events
    • The Tom Isaacs Award
  • About us
    • About Parkinson's
    • People with Parkinson's
    • Our story
    • Policies, partnerships & collaborations
    • Media and brand guidelines
    • Reports & accounts
    • The Trustees
  • Help us
    • Appeals
    • Give regularly
    • Major gifts
    • Challenge events
      • Running
      • Cycling
      • Trekking
      • All challenges
    • Our supporters
      • Fundraiser News
      • Fundraiser of the Year Award
      • Fundraise
        • Fundraising tips
        • Other ways to fundraise
    • Trusts & Foundations
    • Corporates
    • Legacy & In Memoriam
  • News & events
    • News
    • All events
    • Archive news
  • Get in touch
  • Shop
  • Donate
  • Administration
    • Log in
  • Basket: (0 items)

The Trustees

                                                                                                                  Charlie Ralph joined The Cure Parkinson’s Trust as Chair in July 2017. The challenges of Parkinson’s were made real to Charlie when he and his family saw the 20 year pathway experienced by their father following his diagnosis with the condition. Charlie brings a wealth of financial and commercial experience to the trust built during both his role as Chief Financial Officer to a number of private equity backed businesses mostly in the healthcare and technology area as well as from his earlier career in mergers and acquisitions in the City.

     

Kerry Rock has over 25 years experience in research, policy and management from across the not for profit, commercial and government sectors. Kerry joined Prospecting for Gold as Director of Business Development in 2012, following six years at Action Planning. Prior to that, she ran her own research and communication consultancy. Kerry is a member of the Institute of Fundraising, the Culture Sector Network research committee, the UK Branch of the University of Melbourne Alumni Association and the Market Research Society.  

                                                                                                                                   

David Tyndall is a Chartered Accountant, with extensive commercial experience. Originally from Ireland (Mayo and Dublin), David has lived in London for over 30 years and up to 2017 managed a successful land/property business with extensive landholdings in East Anglia. Since 2017 David was Interim Chief Operations Officer (COO) and Chief Financial Officer (CFO) of a large London University and has undertaken other consulting assignments.

   

David Murray began his career in the Royal Air Force and subsequently at British Aerospace. He spent thirty years as a social welfare practitioner, principally in the voluntary sector. He retired as chief executive of Age Concern Gwent and has served in public life as an NHS board member and with executive responsibility for social services on Newport City Council. He also chaired the Newport Housing Commission.

David was diagnosed with Parkinson's in 2007 and in retirement, champions the cause of The Cure Parkinson's Trust as a member of the Wales Neurological Alliance and the Cardiff BRAIN unit. He chairs the governors of Ysgol Gymraeg Cwm Gwyddon. 

Lyndsey Isaacs has been involved with The Cure Parkinson's Trust since its inception in 2005. She was married to the late Tom Isaacs, co-founder and President of The Cure Parkinson’s Trust. Lyndsey runs a busy private acupuncture practice in both Hertfordshire and London and enjoys long walks with her dog Indi. She believes with her experience of living with Tom that she will help maintain the wonderful sense of hope and optimism that has always been at the forefront of the charity.                                                                                                                                                                                                                                                                                           

Dr Peter Fletcher is a consultant physician in the department of old age medicine at Gloucestershire Hospitals NHS Foundation Trust. He specialises in movement disorders and shares service delivery with colleagues in old age medicine, neurology and psychiatry as well as colleagues from nursing and the allied health professions. 

He is a founder member of and educational advisor to the Parkinson’s Academy and has contributed to all masterclasses from their inception in 2002 to date. He is  president of the Cheltenham branch of Parkinson’s UK and local principal investigator for the PDMED (PD medicines), PDGEN (PD genetics) and PDREHAB (PD rehabilitation) studies.                                                                                                                                                                                                                                                          

 David Ashford-Jones founded his international consultancy business, Sagio in 2011. Following a successful 25 year career in the pharmaceutical industry where he held senior roles in training, sales and marketing, David was diagnosed with Parkinson's in 2010 and has since been an active advocate and supporter of The Cure Parkinson's Trust contributing to the 'Rallying to the Challenge' project and resulting research publications. David is determined to change the choice of treatments he is currently faced with and is pursuing a business model for generating funds for Parkinson's research.                                                                                                                                                                                                                                                       

Dame Barbara Logan Hay DCMG LVO MBE is a British diplomat who served as consul-general in Los Angeles for four years until 2013.

Barbara was appointed first new consul-general in St Petersburg in 1991. In 1992, she returned to London, before being appointed as ambassador to Uzbekistan and concurrently (non-resident) ambassador to Tajikistan in 1995. She was the first female ambassador in Tashkent. In 2000, she returned to St Petersburg for a second stint as consul-general until 2004. Barbara then took up the post as consul-general in Los Angeles in 2009.                                                                                                                                                                                                                                        

Peter Berners-PricePeter Berners-Price started his career in hotel management before founding specialist conference management service and corporate communications company Spectrum Communications in 1976. The company grew to employ 150 people with an extensive blue-chip and government client list, handling such high profile events as the EU Presidency Conferences and the Hong Kong Farewell Ceremony. Peter handled negotiations for two subsequent business mergers which eventually created Jack Morton Worldwide.

Published: 1st January, 2020

Updated: 28th July, 2020

Author: Suzanne Bailey

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Raid Local 2021: Ventoux Local

    Raid Local 2021: Ventoux Local

    Join us on the 16th May for Raid Local 2021: Ventoux Local. Inspired by the infamous Club des Cinglés challenge to climb Mont Ventoux using 3 different routes in one day, riders will be training, planning and mapping to cover the equivalent distance and vertical ascent of 1, 2 or all 3 of those epic routes, all in one day, all on their local roads.

  • 3P - Post Doc Seminar - 21 January

    3P - Post Doc Seminar - 21 January

    Join the 3P Seminar on Thursday 21st January (12.00 EST), as Kyla Germain, PhD Candidate in Peter Kim’s lab at The Hospital for Sick Children (University of Toronto), and Tim König, Postdoctoral Researcher in Heidi McBride’s lab at Montreal Neurological Institute (McGill University), present their research.

  • Virtual Bridge Tournament

    Virtual Bridge Tournament

    The Cure Parkinson’s Trust (CPT) supporter Pam Willis will be holding her annual bridge tournament ‘virtually’ on 25 January in support of our pioneering Parkinson’s research and would love you to join her.

  • Virtual Bridge Tournament

    Virtual Bridge Tournament

    The Cure Parkinson’s Trust (CPT) supporter Pam Willis will be holding her annual bridge tournament ‘virtually’ on 25 January 2021 in support of our pioneering Parkinson’s research and would love you to join her.

Most read

  • Breakthrough in stem cell treatment for Parkinson's

    In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

  • Tom Isaacs

    Tom Isaacs

    We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.

  • New Evidence Suggests Parkinson's Might Not Start in The Brain

    New Evidence Suggests Parkinson's Might Not Start in The Brain

    A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...

  • Science news

    Science news

    Read the latest Parkinson's science and research news here.

  • Trials - Repurposed Drugs

    Trials - Repurposed Drugs

    Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

  • Apply for Funding

    Apply for Funding

  • The NAC Trial - the facts

    The NAC Trial - the facts

  • Our story

    Our story

  • Diabetes Drug Potential Disease-Modifying Therapy

    Diabetes Drug Potential Disease-Modifying Therapy

    The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.

  • Alpha-synuclein and Parkinson's

    Alpha-synuclein and Parkinson's

Tag cloud

cell replacement therapy codicil Cure diabetes direct debit flowers GDNF GLP-1 Inflammation Leicestershire Country Cricket parkinsons Parkinson's placebo present Sense Park stem cells
The Science of Parkinson's - Dr Simon Stott, Deputy Director of Research

The Science of Parkinson's - Dr Simon Stott, Deputy Director of Research

Read more

Published: 2nd March, 2015

Updated: 4th August, 2020

Author: Jessica Wright

Science news

Science news

Read the latest Parkinson's science and research news here. Read more

Published: 2nd March, 2015

Updated: 1st December, 2020

Author: Jessica Wright

Related topics:
  • Projects and Progress
The Cure Collective

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Published: 3rd March, 2015

Updated: 28th July, 2020

Author: Jessica Wright

Related topics:
  • Major gifts
Parkinson's Movement

Parkinson's Movement

Read more

Published: 3rd March, 2015

Updated: 6th July, 2020

Author:

Latest tweet

  • Are you an early career scientist wondering what you can do to further your career during this time? If so, join ou… https://t.co/IEAVuHTB9R

    20thJanuary, 2021 @CureParkinsonsT
  • CPT supporter Pam Willis will be holding her annual Bridge tournament virtually, on 25 January. Take part from the… https://t.co/5yM0wMsPQK

    20thJanuary, 2021 @CureParkinsonsT
  • RT @Gavin_W_LeCol: To those that took part in the @CureParkinsonsT @GoZwift #virtual #chase with Tindall vs DROPS Le Col that would b… https://t.co/VQgcVGAZbk

    20thJanuary, 2021 @CureParkinsonsT

Facebook

Stay in touch

  • Email us
  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Instagram
+44 (0)20 7487 3892


SIGN UP TO RECEIVE OUR NEWSLETTERS

The Cure Parkinson’s Trust is a registered charity in England & Wales (1111816) and Scotland (SCO44368)

Terms and conditions Privacy Policy Sitemap Cookie policy Accessibility


Please note that due to current COVID restrictions and extensive home working there may be a slight delay in posting certain items from our Shop.
If you would like to discuss anything relating to a purchase, please email [email protected] – thank you for your patience. The CPT Team.